Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

Jean Hee Kim; Silvia Park; Woojun Kim

doi:10.1007/s10072-022-06124-6

Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

Jean Hee Kim
, Silvia Park
, Woojun Kim

Department of Internal Medicine

Catholic Univ. of Korea Coll. Med.

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	5651-5653
Number of pages	3
Journal	Neurological Sciences
Volume	43
Issue number	9
DOIs	https://doi.org/10.1007/s10072-022-06124-6
State	Published - Sep 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10072-022-06124-6

Cite this

@article{89fdbbf195a24ec980d9b2e3edebe82a,

title = "Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient",

author = "Kim, \{Jean Hee\} and Silvia Park and Woojun Kim",

year = "2022",

month = sep,

doi = "10.1007/s10072-022-06124-6",

language = "English",

volume = "43",

pages = "5651--5653",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia s.r.l.",

number = "9",

}

TY - JOUR

T1 - Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

AU - Kim, Jean Hee

AU - Park, Silvia

AU - Kim, Woojun

PY - 2022/9

Y1 - 2022/9

UR - https://www.scopus.com/pages/publications/85129828226

U2 - 10.1007/s10072-022-06124-6

DO - 10.1007/s10072-022-06124-6

M3 - Letter

C2 - 35543831

AN - SCOPUS:85129828226

SN - 1590-1874

VL - 43

SP - 5651

EP - 5653

JO - Neurological Sciences

JF - Neurological Sciences

IS - 9

ER -

Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

UN SDGs

Access to Document

Other files and links

Cite this